Sphingolipids, a highly enriched pathway in this KEGG analysis, were able to contribute to the biogenesis regulation of Aβ, tau, ⍺-Syn, and APOE that are biomarkers of AD pathogenesis (Wang X et al. 2024). This evidence concerns the gene MAPT and Alzheimer disease.